Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Harbor MedTech raises $5m for regenerative soft tissue repair tech
Harbor MedTech said yesterday that it raised nearly $5 million for the regenerative treatments for soft tissue repair it developed. The Irvine, Calif.-based company said 3 unnamed investors participated in the equity round, which aims to raise a total of nearly $8.5 million. Read more
4. CMS: Mylan overcharged Medicaid for EpiPens for years
The Centers for Medicare & Medicaid Services said this week that Mylan Pharmaceuticals has been overcharging Medicaid for its EpiPen auto-injector for years, despite being warned that it should have paid bigger rebates. Read more
3. Evolent closes Valence buyout, adding $74m to price
Evolent Health said this week that it closed its acquisition of value-based administration, population health and advisory services provider Valence Health – but spent a lot more than the original $145 million it put on the table. Read more
2. Boston Scientific launches tender offer for EndoChoice
Boston Scientific said today that it launched the tender offer for its pending, $210 million acquisition of EndoChoice and its line of devices for treating gastrointestinal disease. Read more
1. Sotera Wireless files for Chapter 11 bankruptcy
Sotera Wireless last month filed for Chapter 11 bankruptcy protectection, saying it owes its creditors, Silicon Valley Bank and Oxford Finance, roughly $13.1 million and doesn’t have the scratch to make good. Read more
The post MassDevice.com +5 | The top 5 medtech stories for October 7, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2dkH2zs
Cap comentari:
Publica un comentari a l'entrada